Human TLR3 Antibody Summary
Lys27-Ser711
Accession # Q6PCD4
Applications
Please Note: Optimal dilutions should be determined by each laboratory for each application. General Protocols are available in the Technical Information section on our website.
Scientific Data
Detection of Human TLR3 by Western Blot. Western blot shows lysates of Jurkat human acute T cell leukemia cell line and HeLa human cervical epithelial carcinoma cell line. PVDF membrane was probed with 2 µg/mL of Mouse Anti-Human TLR3 Monoclonal Antibody (Catalog # MAB1487) followed by HRP-conjugated Anti-Mouse IgG Secondary Antibody (Catalog # HAF007). A specific band was detected for TLR3 at approximately 116 kDa (as indicated). This experiment was conducted under non-reducing conditions and using Immunoblot Buffer Group 1.
Detection of Human TLR3 by Western Blot Knocking-down TLR3 suppresses enhancement of c-IAP2 protein expression by poly(I:C). Western blot analysis of protein extracts from HeLa cells treated with poly(I:C) (500 ng/ml for 16 h) with or without pre-treatment with TLR3-specific and control (NS) siRNAs. The same membrane was stained successively with anti-c-IAP2, TLR3 and beta -actin. Note that the control siRNA by itself enhanced TLR3 and c-IAP2 expression. This is consistent with previous observations and possibly related to the interaction of these small double-strand RNAs with the TLR3 itself regardless of their sequence [36]. In our transfection protocol siRNAs are at 100 nM for the first 4 h and 50 nM for the next 44 h. TLR3 inhibition was not complete with the siRNA n°1 which was apparently weaker than the siRNA n°2. However the siRNA n°1 was strong enough to prevent enhancement of TLR3 and c-IAP2 expression in the absence of poly(I:C). Data are representative of two similar experiments. Image collected and cropped by CiteAb from the following publication (https://pubmed.ncbi.nlm.nih.gov/20576118), licensed under a CC-BY license. Not internally tested by R&D Systems.
Reconstitution Calculator
Preparation and Storage
- 12 months from date of receipt, -20 to -70 °C as supplied.
- 1 month, 2 to 8 °C under sterile conditions after reconstitution.
- 6 months, -20 to -70 °C under sterile conditions after reconstitution.
Background: TLR3
Human TLR3 is a 116 kDa type I transmembrane glycoprotein that belongs to the mammalian Toll-Like Receptor family of pathogen pattern recognition molecules (1, 2). There are at least eleven mouse and ten human members that activate the innate immune system following exposure to a variety of microbial species (3). The human TLR3 cDNA encodes a 904 amino acid (aa) precursor that contains a 23 aa signal sequence, a 681 aa extracellular domain (ECD), a 21 aa transmembrane segment, and a 179 aa cytoplasmic region (4). The horseshoe shaped ECD (5, 6) contains 23 leucine rich repeats, and the cytoplasmic domain contains one Toll/IL-1 receptor (TIR) domain. The ECD of human TLR3 shares 80%, 79%, and 77% aa sequence identity with the ECD of rat, mouse, and bovine TLR3, respectively. TLR3 is found in phagosomes (7), where the acidic pH enables binding of internalized double stranded RNA and mRNA from viruses, parasites, and necrotic virally-infected cells (8‑11). Ligand binding by TLR3 induces receptor dimerization (5, 6, 8) leading to the release of inflammatory cytokines and dendritic cell maturation (9, 11‑13). TLR3 is expressed in dendritic cells, macrophages, microglia, and astrocytes (13‑15) and is upregulated by IFN-beta and LPS (9, 14). TLR3 expression is also induced by lung fibroblasts and epithelial cells by respiratory syncytial virus infection (12).
- Sen, G.C. and S.N. Sarkar (2005) Cytokine Growth Factor Rev. 16:1.
- Schroder, M. and A.G. Bowie (2005) Trends Immunol. 26:462.
- Hopkins, P.A. and S. Sriskandan (2005) Clin. Exp. Immunol. 140:395.
- Rock, F.L. et al. (1998) Proc. Natl. Acad. Sci. 95:588.
- Choe, J. et al. (2005) Science 309:581.
- Bell, J.K. et al. (2005) Proc. Natl. Acad. Sci. 102:10976.
- Nishiya, T. et al. (2002) J. Biol. Chem. 280:37107.
- de Bouteiller, O. et al. (2005) J. Biol. Chem. 280:38133.
- Alexopoulou, L. et al. (2001) Nature 413:732.
- Aksoy, E. et al. (2005) J. Biol. Chem. 280:277.
- Kariko, K. et al. (2004) J. Biol. Chem. 279:12542.
- Rudd, B.D. et al. (2005) J. Virol. 79:3350.
- Farina, C. et al. (2005) J. Neuroimmunol. 159:12.
- Heinz, S. et al. (2003) J. Biol. Chem. 278:21502.
- Wang, T. et al. (2004) Nat. Med. 10:1366.
Product Datasheets
Citations for Human TLR3 Antibody
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
6
Citations: Showing 1 - 6
Filter your results:
Filter by:
-
Thymosin alpha-1 reverses M2 polarization of tumor-associated macrophages during efferocytosis
Authors: YT Wei, XR Wang, C Yan, F Huang, Y Zhang, X Liu, ZF Wen, XT Sun, Y Zhang, YQ Chen, R Gao, N Pan, LX Wang
Cancer Research, 2022-05-16;0(0):.
Species: Human
Sample Types: Cell Lysates
Applications: Western Blot -
Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.
Authors: Walker D, Tang T, Lue L
Exp Neurol, 2018-08-01;309(0):91-106.
Species: Human
Sample Types: Tissue Homogenates
Applications: Western Blot -
Stimulation of the toll-like receptor 3 promotes metabolic reprogramming in head and neck carcinoma cells
Authors: Mathieu Veyrat, Sylvère Durand, Marion Classe, Tanja Matijevic Glavan, Natalie Oker, Nikiforos-Ioannis Kapetanakis et al.
Oncotarget
-
Toll-like receptor 3 in Epstein-Barr virus-associated nasopharyngeal carcinomas: consistent expression and cytotoxic effects of its synthetic ligand poly(A:U) combined to a Smac-mimetic
Authors: Benjamin Vérillaud, Mélanie Gressette, Yannis Morel, Carine Paturel, Philippe Herman, Kwok Wai Lo et al.
Infectious Agents and Cancer
-
Rb/E2F1 Regulates the Innate Immune Receptor Toll-Like Receptor 3 in Epithelial Cells
Authors: Manabu Taura, Mary Ann Suico, Kosuke Koyama, Kensei Komatsu, Rui Miyakita, Chizuru Matsumoto et al.
Molecular and Cellular Biology
-
Poly(I:C) induces intense expression of c-IAP2 and cooperates with an IAP inhibitor in induction of apoptosis in cancer cells
Authors: Luc Friboulet, Claire Gourzones, Sai Wah Tsao, Yannis Morel, Carine Paturel, Stéphane Témam et al.
BMC Cancer
FAQs
No product specific FAQs exist for this product, however you may
View all Antibody FAQsReviews for Human TLR3 Antibody
There are currently no reviews for this product. Be the first to review Human TLR3 Antibody and earn rewards!
Have you used Human TLR3 Antibody?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image